CliffBio
small molecule

CARBINOXAMINE MALEATE

CARBINOXAMINE MALEATE

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCARBINOXAMINE MALEATE
Active ingredientCARBINOXAMINE MALEATE
Strength4MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalApril 2003
Marketing statusRX

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CARBINOXAMINE MALEATE patent cliff — loss of exclusivity — | CliffBio